JP Morgan Chase’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.6M Sell
452,979
-21,838
-5% -$2.14M ﹤0.01% 1504
2025
Q4
$46.2M Sell
474,817
-22,045
-4% -$2.09M ﹤0.01% 1416
2025
Q3
$44M Sell
496,862
-29,295
-6% -$2.53M ﹤0.01% 1494
2025
Q2
$45.3M Sell
526,157
-3,581
-0.7% -$308K ﹤0.01% 1389
2025
Q1
$48.3M Sell
529,738
-39,787
-7% -$3.61M ﹤0.01% 1332
2024
Q4
$49M Sell
569,525
-54,144
-9% -$5M ﹤0.01% 1342
2024
Q3
$61.2M Buy
623,669
+571
+0.1% +$55.4K ﹤0.01% 1202
2024
Q2
$57.8M Buy
623,098
+5,807
+0.9% +$530K 0.01% 1177
2024
Q1
$57.5M Sell
617,291
-14,159
-2% -$1.28M 0.01% 1210
2023
Q4
$54.8M Sell
631,450
-155,227
-20% -$12.9M 0.01% 1167
2023
Q3
$64.8M Buy
786,677
+113,286
+17% +$9.61M 0.01% 999
2023
Q2
$57.2M Buy
673,391
+31,449
+5% +$2.68M 0.01% 1068
2023
Q1
$53.5M Buy
641,942
+41,398
+7% +$3.43M 0.01% 1074
2022
Q4
$51M Buy
600,544
+80,676
+16% +$6.65M 0.01% 1106
2022
Q3
$39.2M Buy
519,868
+1,825
+0.4% +$148K 0.01% 1160
2022
Q2
$42M Sell
518,043
-47
-0% -$3.93K 0.01% 1143
2022
Q1
$45.4M Buy
518,090
+31,641
+7% +$2.68M 0.01% 1216
2021
Q4
$43.9M Buy
486,449
+26,870
+6% +$2.32M 0.01% 1270
2021
Q3
$38.5M Buy
459,579
+34,687
+8% +$3M 0.01% 1318
2021
Q2
$35.3M Buy
424,892
+20,150
+5% +$1.63M ﹤0.01% 1402
2021
Q1
$31.2M Buy
404,742
+16,221
+4% +$1.25M ﹤0.01% 1417
2020
Q4
$29.7M Buy
388,521
+26,524
+7% +$1.95M ﹤0.01% 1343
2020
Q3
$25.8M Buy
361,997
+10,864
+3% +$779K ﹤0.01% 1333
2020
Q2
$24.2M Buy
351,133
+348,463
+13,051% +$23.5M ﹤0.01% 1252
2020
Q1
$162K Hold
2,670
﹤0.01% 4352
2019
Q4
$184K Sell
2,670
-6,491
-71% -$421K ﹤0.01% 4701
2019
Q3
$559K Sell
9,161
-439,634
-98% -$26.9M ﹤0.01% 4122
2019
Q2
$27.6M Buy
448,795
+444,895
+11,408% +$26.7M 0.01% 1333
2019
Q1
$238K Sell
3,900
-50
-1% -$2.98K ﹤0.01% 4544
2018
Q4
$224K Sell
3,950
-750
-16% -$44.9K ﹤0.01% 4542
2018
Q3
$296K Sell
4,700
-1,092
-19% -$66K ﹤0.01% 4534
2018
Q2
$327K Buy
5,792
+650
+13% +$36.7K ﹤0.01% 4355
2018
Q1
$286K Sell
5,142
-10,104
-66% -$581K ﹤0.01% 4234
2017
Q4
$857K Sell
15,246
-1,300
-8% -$73.1K ﹤0.01% 3805
2017
Q3
$924K Buy
16,546
+800
+5% +$44K ﹤0.01% 3558
2017
Q2
$861K Buy
15,746
+12,982
+470% +$690K ﹤0.01% 3502
2017
Q1
$142K Hold
2,764
﹤0.01% 4201
2016
Q4
$131K Buy
2,764
+500
+22% +$24K ﹤0.01% 4318
2016
Q3
$114K Sell
2,264
-5,100
-69% -$262K ﹤0.01% 3836
2016
Q2
$372K Buy
7,364
+6,600
+864% +$329K ﹤0.01% 3550
2016
Q1
$37K Hold
764
﹤0.01% 3965
2015
Q4
$39K Sell
764
-4,140
-84% -$213K ﹤0.01% 3964
2015
Q3
$241K Sell
4,904
-3,070
-39% -$166K ﹤0.01% 3635
2015
Q2
$433K Buy
7,974
+1,876
+31% +$103K ﹤0.01% 3606
2015
Q1
$329K Buy
6,098
+874
+17% +$45.8K ﹤0.01% 3669
2014
Q4
$260K Buy
+5,224
New +$260K ﹤0.01% 3932
2014
Q2
Sell
-18,934
Closed -$862K 3570
2014
Q1
$862K Sell
18,934
-49,948
-73% -$2.23M ﹤0.01% 2910
2013
Q4
$2.97M Buy
68,882
+42,720
+163% +$1.78M ﹤0.01% 2494
2013
Q3
$1.04M Buy
+26,162
New +$1.02M ﹤0.01% 3237

Other funds holding IXJ